Michiel de Haan
Founder at Aescap Venture Management BV
Profile
Michiel de Haan is the founder of Atlas Venture, a venture capital company with offices in Boston, London, Paris and Munich.
Atlas has been involved in more than 300 venture-backed companies.
From 1980 to 2000 Michiel served as managing partner of Atlas Venture.
His personal venture management involvement within Atlas was focussed on Life Science companies in which he held numerous board seats.
In 1974 Michiel received an MBA from Erasmus University in Rotterdam.
From 1974 till 1980 he worked at NMB (now ING).
He represented the bank in the earliest Dutch Venture Capital Funds and started NMB-Participatie, which he later bought to create Atlas Venture.
The Founders have successfully worked together since 1993, when Dinko Valerio founded IntroGene B.V.
(the predecessor of Crucell N.V.) and Atlas Venture acted as seed investor.
Michiel de Haan joined the Supervisory Board as Vice Chairman and also became the Chairman of Crucell’s Audit Committee.
This was the basis of a solid working relation between Dinko and Michiel.
This relationship, their complementary skills and networks form the basis of the plan to create AESCAP Venture.
Michiel de Haan active positions
| Companies | Position | Start |
|---|---|---|
Aescap Venture Management BV
 Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Founder | 2004-12-31 |
Avantium Technologies BV
 Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Director/Board Member | - |
Former positions of Michiel de Haan
| Companies | Position | End |
|---|---|---|
| AVANTIUM N.V. | Director/Board Member | 2017-03-14 |
ProtAffin Biotechnologie AG
 ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology ProtAffin was spun out of the Karl-Franzens University of Graz in July 2005. The company currently employs 16 people in modern office and laboratory facilities in Graz and Vienna and plans to expand to 27 by the end of 2009. They are well financed by a syndicate of 5 international venture capital investors. The company has a balanced 'platform-product' strategy: a lead compound in pre-clinical development and a core discovery technology by which they are supporting a sustainable pipeline of products via its unique CellJammer® discovery technology platform. ProtAffin is leveraging its leading technical expertise in protein-glycan interactions to develop novel biological products. They are currently collaborating with a number of university groups in Austria, Germany, Brazil and the UK. They plan to collaborate with Pharma and Biotech companies interested to access its technology for the development of novel anti-inflammatory products with a unique mechanism of action. | Director/Board Member | 2014-02-16 |
| European Venture Philanthropy Association | Founder | - |
| The European Venture Capital Association | Chairman | - |
Training of Michiel de Haan
| Erasmus University Rotterdam | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVANTIUM N.V. | Producer Manufacturing |
| Private companies | 5 |
|---|---|
Avantium Technologies BV
Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Commercial Services |
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Finance |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology ProtAffin was spun out of the Karl-Franzens University of Graz in July 2005. The company currently employs 16 people in modern office and laboratory facilities in Graz and Vienna and plans to expand to 27 by the end of 2009. They are well financed by a syndicate of 5 international venture capital investors. The company has a balanced 'platform-product' strategy: a lead compound in pre-clinical development and a core discovery technology by which they are supporting a sustainable pipeline of products via its unique CellJammer® discovery technology platform. ProtAffin is leveraging its leading technical expertise in protein-glycan interactions to develop novel biological products. They are currently collaborating with a number of university groups in Austria, Germany, Brazil and the UK. They plan to collaborate with Pharma and Biotech companies interested to access its technology for the development of novel anti-inflammatory products with a unique mechanism of action. | Health Technology |
| The European Venture Capital Association | |
| European Venture Philanthropy Association |
- Stock Market
- Insiders
- Michiel de Haan
